Variable | Period | Placebo group (n = 45) | Synbiotic group (n = 45) | MD (95% CI)a between groups | P value | Effect Size (Cohen’s d)b |
---|---|---|---|---|---|---|
MDA (μmol/L) | Initial | 1.78 (0.45) | 1.82 (0.82) | 0.04 (−0.24, 0.32) | 0.78 |  |
End | 1.77 (0.46) | 1.89 (0.42) | 0.12 (−0.05, 0.29) | 0.28 | 0.16 | |
MD (95% CI) within groupsc | 0.01 (−0.16 to 0.15) | 0.07 (−0.15 to 0.29) |  |  |  | |
P value | 0.9 | 0.49 | Â | Â | Â | |
hs-CRP (μg/mL) | Initial | 5.17 (2.47, 7.46) | 4.52 (2.9, 11.4) | −0.92 | 0.57 |  |
End | 5.9 (3.1, 8.3) | 4.4 (2.68, 11.35) | −1.5 | 0.66 | 0.11 | |
Median difference | 0.73 | −0.12 |  |  |  | |
P value | – | – |  |  |  | |
TC/HDL-C | Initial | 4.26 (1.25) | 4.46 (1.95) | 0.2 (−0.49, 0.88) | 0.58 |  |
End | 4.45 (1.19) | 4.18 (1.25) | −0.27, −0.78, 0.24) | 0.06 | 0.12 | |
MD(95% CI) within groupsc | 0.19 (−0.18, 0.54) | −0.28 (−0.75, 0.2) |  |  |  | |
P value | 0.31 | 0.25 | Â | Â | Â | |
LDL-C/HDL-C | Initial | 2.54 (0.87) | 2.73 (1.6) | 0.19 (−0.36, 0.73) | 0.73 |  |
End | 2.62 (0.88) | 2.45 (0.96) | −0.17 (−0.56, 0.22) | 0.06 | 0.1 | |
MD(95% CI) within groupsc | 0.08 (−0.22, 0.36) | −0.28 (−0.76, 0.2) |  |  |  | |
P value | 0.59 | 0.19 | Â | Â | Â | |
logTG/HDL-C | Initial | 0.48 (0.25) | 0.48 (0.28) | 0.001 (−0.11, −0.15) | 0.97 |  |
End | 0.55 (0.26) | 0.43 (0.25) | −0.11 (−0.21, 0) | 0.003 | 0.25 | |
MD(95% CI) within groupsc | 0.07 (0.02, 0.12) | −0.05 (−0.09, 0.01) |  |  |  | |
P value | 0.02 | 0.042 | Â | Â | Â |